Background {#Sec1}
==========

It is generally accepted that performance of gastrectomy in gastric cancer patients can lead to an increased incidence of cholecystolithiasis (CL) and a higher rate of morbidities that require secondary surgery \[[@CR1]\], which may related with the complex interaction between sectioning of the nerve supply to the gallbladder and the change in cholecystokinin secretion \[[@CR2], [@CR3]\]. However, performance of routine prophylactic cholecystectomy during radical gastrectomy is still being debated \[[@CR4]\]. The aim of this study was to investigate the correlative factors that contribute to gallstone formation and later cholecystectomy in patients with previous radical gastrectomy. The influences of simultaneous cholecystectomy on surgical mortality and morbidity of gastric cancer patients were also evaluated.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

A total of 1753 gastric cancer patients underwent radical gastrectomy at the Department of Surgery, Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital), China from January 2010 to March 2018. The diagnosis of gastric cancer was confirmed by postoperative pathological examination of the resected specimen. The study was approved by the Ethics Committee of Huzhou Hospital, Zhejiang University School of Medicine, and written informed consent was obtained from all patients. In all patients, 1691 had no gallstones and preserved their gallbladders during radical gastrectomy. These patients were all followed-up and the median follow-up period after first surgery was 45 months (range: 11--96 months). Their gallbladders were routinely examined by ultrasonography or computed tomography during the postoperative period and 152 patients were diagnosed CL after gastric resection. Of these patients, 45 patients underwent a secondary cholecystectomy followed the following surgical indications: cholecystolithiasis combined with conservative treatment of uncontrollable cholecystitis (more than 3 times per month); complicated with acute pancreatitis; gallstones larger than 2 cm in diameter; cholecystolithiasis combined with gallbladder polyp; porcelain gallbladder; gallbladder atrophy; gallbladder filling stones; gallstones located in the gallbladder ampulla abdomen or gallbladder duct. Sixty-two patients with gallstones underwent simultaneous cholecystectomy during radical gastrectomy. A flow chart for the treatment of the gastric cancer patients with or without cholecystolithiasis is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow chart showing the treatment of the gastric cancer patients with or without cholecystolithiasis

Study protocol {#Sec4}
--------------

A total of 1691 gastric cancer patients without gallstones were evaluated retrospectively to determine the risk factors for cholecystolithiasis and later cholecystectomy. The clinicopathological characteristics of all patients were documented. The patients were grouped according to age (≤75/\> 75 years), sex, rate of postoperative body mass index (BMI) decrease in 3 months \[(preoperative BMI -- postoperative BMI 3 months after surgery) / preoperative BMI × 100%\] (≤5%/\> 5%), cTNM stage, tumor differentiation grade, type of gastrectomy, extent of lymph node dissection, and presence of diabetes mellitus (yes/no). The tumor differentiation grades followed the criteria in the Edmondson--Steiner classification, and divided the patients into groups with well-differentiated tumors (Grade I), moderately-differentiated tumors (Grade II), and poorly-differentiated tumors (Grade III). Tumor stages were assigned according to the UICC TNM classification (7th edition). Then these groups were divided again to postoperative cholecystolithiasis (yes/no) and subsequent cholecystectomy (yes/no) groups for further study. The clinical outcomes of the 1691 patients who underwent gastrectomy only and the 62 patients who underwent combined surgery were reviewed retrospectively and documented, including postoperative mortality, postoperative wound infection, anastomotic leak, duodenal stump leak, gastric stasis, intraabdominal abscess, hemorrhage, pulmonary infection, diarrhea, postoperative pancreatitis, and cholangitis. The mortality and morbidity rates in the two groups were compared to determine the influence of simultaneous cholecystectomy on surgical safety of radical gastrectomy.

Statistical analysis {#Sec5}
--------------------

All data were prepared and compiled using SPSS software (version 19.0 for Windows; IBM Corp., Armonk, NY, USA). The Chi-square test and Fisher's exact test were used for quantitative data. Risk factors were analyzed by logistic regression analysis. A *p*-value \<0.05 was considered statistically significant.

Results {#Sec6}
=======

Patient characteristics {#Sec7}
-----------------------

The characteristics of the 1691 patients who did not undergo simultaneous cholecystectomy during gastric resection are shown in Table [1](#Tab1){ref-type="table"}. The patients comprised 1222 males and 469 females, with a male-to-female ratio of 2.61:1 and an age range of 23--84 years (median age: 61 years). Regarding the gastric cancer stages, stage I was diagnosed in 534 (31.6%) patients, stage II in 712 (42.1%) patients, and stage III in 445 (26.3%) patients. For tumor differentiation grades, Grade I was present in 617 (36.5%) patients, Grade II in 523 (30.9%) patients, and Grade III in 551 (32.6%) patients. Billroth I reconstruction was performed in 334 (19.8%) patients, Billroth II in 876 (51.8%) patients, and total gastrectomy and Roux-en-Y reconstruction in 481 (28.4%) patients. D1 lymph node dissections were carried out in 264 (15.6%) patients, and D2 lymph node dissections in 1427 (84.4%) patients. A total of 152 patients had gallstones after gastrectomy and the incidence of cholecystolithiasis was 8.98% (152/1691). Forty-five patients underwent later cholecystectomy, giving a subsequent operation rate of 2.67% (45/1691).Table 1Clinicopathological characteristics of 1691 gastric cancer patients who underwent gastrectomy without cholecystectomy (median age: 61.0 ± 10.5 years; age range: 23--84 years)VariableNo. of patients (%)Gender Male1222 (72.3%) Female469 (27.7%)TNM stage Stage I534 (31.6%) Stage II712 (42.1%) Stage III445 (26.3%)Tumor differentiation grade Grade I617 (36.5%) Grade II523 (30.9%) Grade III551 (32.6%)Method of gastrectomy Billroth I334 (19.8%) Billroth II876 (51.8%) Roux-en-Y481 (28.4%)Lymph node dissection D1264 (15.6%) D21427 (84.4%) Cholecystolithiasis after gastrectomy152 (8.98%) Subsequent cholecystectomy after gastrectomy45 (2.67%)

Risk factors fo2r cholecystolithiasis after gastrectomy {#Sec8}
-------------------------------------------------------

The median interval from gastrectomy to development of cholecystolithiasis was 37.5 months (range: 8.0--94.7 months) and 152 patients had gallstones after gastrectomy, giving an incidence of cholecystolithiasis of 8.98%. Univariate analyses showed that postoperative BMI decrease \>5% in 3 months, method of gastrectomy (Roux-en-Y, Billroth II), and diabetes mellitus were significantly associated with occurrence of gallstone formation (*p* = 0.002, *p* = 0.018, and *p* = 0.038, respectively). Logistic regression analysis identified these clinicopathological features as risk factors for occurrence of cholecystolithiasis after gastrectomy \[BMI decrease (\> 5%/≤5%): OR (95%CI): 1.812 (1.225--2.681), *p* = 0.003; gastrectomy method (no-Billroth I/Billroth I): OR (95%CI): 1.801 (1.097--2.959), *p* = 0.002; diabetes mellitus (yes/no): OR (95%CI): 1.544 (1.030--2.316), *p* = 0.036\], as shown in Table [2](#Tab2){ref-type="table"}.Table 2Correlations between the clinicopathological characteristics of 1691 gastric cancer patients and postoperative cholecystolithiasisVariablesPostoperative cholecystolithiasisχ2*p* valueOdds ratio (95% CI)*p* valueYes (*n* = 152)No (*n* = 1539)Age (years) \>75344121.3810.288 ≤751181127Gender Male10511170.8460.393 Female47422BMI decreased rate ≤5%355419.0570.002\*10.003\* \>5%1179981.812 (1.225--2.681)TNM stage Stage I+ II11411320.1490.699 Stage III38407Tumor differentiation grade Grade I + II9610441.3780.240 Grade III56495Method of gastrectomy Billroth I193155.5410.018\*10.002\* No-Billroth I13312241.801 (1.097--2.959)Lymph node dissection D1302342.1570.159 D21221305Diabetes mellitus No11812974.4710.038\*10.036\* Yes342421.544 (1.030--2.316)\**p* \< 0.05

Risk factors for subsequent cholecystectomy after gastrectomy {#Sec9}
-------------------------------------------------------------

A total of 45 (2.67%) patients required a subsequent cholecystectomy after gastrectomy. Of these, 34 patients underwent open cholecystectomy and 11 patients underwent laparoscopic cholecystectomy. Univariate analyses showed that method of gastrectomy (Roux-en-Y, Billroth II) and diabetes mellitus were significantly associated with occurrence of later cholecystectomy (*p* = 0.007 and *p* = 0.038, respectively). Logistic regression analysis identified these two clinicopathological features as risk factors for occurrence of subsequent cholecystectomy \[gastrectomy method (no-Billroth I/Billroth I\]: OR (95%CI): 5.432 (1.309--22.539), *p* = 0.020; diabetes mellitus (yes/no): OR (95%CI): 2.136 (1.106--4.125), *p* = 0.024\], as shown in Table [3](#Tab3){ref-type="table"}.Table 3Correlations between the clinicopathological characteristics of 1691 gastric cancer patients and subsequent cholecystectomyVariablesSubsequent cholecystectomyχ2*p* valueOdds ratio (95% CI)*p* valueYes (*n* = 45)No (*n* = 1646)Age (years) \>75114350.0890.865 ≤75341211Gender Male3211900.0310.867 Female13456BMI decreased rate ≤5%95674.0710.055 \>5%361079TNM stage Stage I+ II3212140.1580.732 Stage III13432Tumor differentiation grade Grade I + II3211080.2870.633 Grade III13538Method of gastrectomy Billroth I23326.8340.007\*10.020\* No-Billroth I4313145.432 (1.309--22.539)Lymph node dissection D1102541.5330.213 D2351392Diabetes mellitus No3213835.3460.038\*10.024\* Yes132632.136 (1.106--4.125)\**p* \< 0.05

Postoperative morbidity and mortality rates in the simultaneous cholecystectomy group and gastrectomy only group {#Sec10}
----------------------------------------------------------------------------------------------------------------

Of the total 1793 gastric cancer patients, 62 (3.5%) patients with gallstones underwent simultaneous cholecystectomy during gastric resection. The mortality and morbidity rates did not differ significantly between the combined surgery group and the gastrectomy only group (8.1% vs. 8.9 and 1.6% vs. 2.2%, respectively, *p* \> 0.05), as shown in Table [4](#Tab4){ref-type="table"}.Table 4Postoperative morbidity and mortality rates in the simultaneous cholecystectomy group and the gastrectomy only groupSimultaneous cholecystectomy (*n* = 62)Gastrectomy only (*n* = 1691)χ^2^*p* valuePostoperative morbidity8.1% (4.9)8.9% (145)0.0210.997 Wound infection8.1% (5)8.7% (147)0.0300.991 Hemorrhage3.2% (2)3.3% (55)0.0210.998 Anastomotic leak6.4% (4)7.2% (121)0.0450.997 Duodenal stump leak1.6% (1)1.7% (29)0.0310.992 Gastric stasis12.8% (8)14.8% (251)0.1790.855 Intraabdominal abscess3.2% (2)3.1% (52)0.0220.998 Pulmonary infection6.4% (4)6.7% (114)0.0080.998 Diarrhea17.7% (11)17.4% (295)0.0041.000 Postoperative cholangitis8.1% (5)9.6% (162)0.1590.828 Postoperative pancreatitis11.3% (7)13.2% (224)0.2000.848Postoperative mortality1.6% (1)2.2% (38)0.1111.000

Discussion {#Sec11}
==========

Patients undergoing gastrectomy, especially radical gastrectomy, have a higher incidence of postoperative gallstone formation \[[@CR5], [@CR6]\]. The underlying mechanisms of this phenomenon are unclear. The complex interaction between the supply of cholecystic nerves and the secretion of cholecystokinin may play an important role. In gastric cancer surgery, to achieve better lymph node dissection, the liver branch of the vagus nerve is inevitably damaged. Deletion or damage to the vagus nerve branch can result in impaired gallbladder emptying, which in turn may lead to gallstone formation \[[@CR7], [@CR8]\]. Also, radical gastrectomy usually involves Billroth II and Roux-en-Y techniques, which eliminate food passing through the duodenum, and may reduce secretion of cholecystokinin and gallbladder activity, promoting cholestasis and gallstone formation \[[@CR2]\]. Although several studies confirmed that the incidence of gallstones after gastrectomy is significantly higher than that in patients without upper gastrointestinal surgery, whether there is a need for preventive gallbladder resection in gastric cancer surgery remains controversial. The incidence of gallstones and symptomatic cholelithiasis requiring cholecystectomy after gastric cancer surgery is still relatively low \[[@CR9]\]. In the present study, we observed cholecystolithiasis after gastrectomy in only 8.98% of patients, which was lower than the rates of 13--22% reported in previous studies \[[@CR2], [@CR4], [@CR6]\]. We also found a low incidence of subsequent cholecystectomy of only 2.67% of patients. Based on these data, we believe that not all patients undergoing gastrectomy require routine preventive cholecystectomy. However, our identification of risk factors leading to gallstone formation and subsequent cholecystectomy is important and can help surgeons develop a rational surgical treatment strategy to avoid subsequent surgery or over-treatment.

Various clinical or surgical factors appear to be responsible for the development of cholecystolithiasis or the requirement for subsequent cholecystectomy after radical gastrectomy. Regarding surgical methods, several studies reported that the incidence of gallstone formation was affected by the gastrectomy procedure, especially the type of gastrointestinal reconstruction \[[@CR10]\]. A recently study found that in patients who underwent distal gastrectomy, there are no significant difference in gallstones incidence between performance of Billroth I, Billroth II, or Roux-en-Y anastomosis, but most research results indicated that the incidence of gallstones is higher in patients with Biroth II and Roux-en-Y anastomosis (duodenal exclusion) \[[@CR11]\] and the patients who underwent total gastrectomy with resection of the esophagus and complete vagus nerve stem \[[@CR12]\].

Lymph node dissection during radical gastrectomy is another possible risk factor for gallstone formation and subsequent cholecystectomy. Some studies have shown that the degree of lymph node dissection has an influence on gallstone formation \[[@CR8]\]. More involved lymph node dissections are associated with a higher incidence of gallstones and acute cholecystitis following subsequent surgery than with limited or standard lymph node dissection. D2 lymph node dissection includes dissection along the hepatoduodenal ligament, which may lead to gallstones or cholecystitis by affecting gallbladder emptying, but routine concomitant cholecystectomy and D2 lymph node dissection remains controversial \[[@CR13]\]. Surgical techniques, age, BMI reduction after gastrectomy, and diabetes are candidate risk factors for gallstone formation after gastrectomy. Rapid weight loss can also lead to mobilization of cholesterol stored secondary to gallbladder bile deposition. Supersaturation, as well as cholestasis secondary to bile duct inflammation, can promote gallstone formation \[[@CR14]\].

The effect of diabetes on gallstones is multifactorial; diabetes leads to neuritis and neuromyopathy. In diabetes, increased oxidative stress at low heme oxygenase-1 levels and decreased insulin and insulin-like growth factor-1 signaling lead to loss of interstitial cells of Cajal, which results in abnormal gallbladder emptying and promotes gallstone formation \[[@CR15]\]. Diabetes mellitus is also a well-known risk factor for cholelithiasis, which can lead to subsequent cholecystectomy \[[@CR16]\].

In this retrospective study, we applied Fisher's exact test and logistic regression analysis to identify the risk factors for gallstone formation and subsequent cholecystectomy after radical gastrectomy, and found that postoperative BMI decrease \> 5% in 3 months, gastrectomy method (Roux-en-Y or Billroth II), and diabetes mellitus were independent risk factors for cholecystolithiasis. Roux-en-Y or Billroth II reconstruction and diabetes mellitus were also independent risk factors for subsequent cholecystectomy. These results indicated that prophylactic cholecystectomy may be necessary in patients with Roux-en-Y or Billroth II gastrectomy and with diabetes mellitus. H However, some studies reported that the postoperative complication incidences of simultaneous cholecystectomy during gastrectomy is higher than which of late cholecystectomy \[[@CR12]\]. In our study, there was no significant increase in postoperative morbidity or mortality in patients who underwent cholecystectomy during radical gastrectomy.

In summary, prophylactic and simultaneous cholecystectomy during gastric resection for gastric cancer patients is safe, but does not need to be a routine operation for all patients undergoing radical gastrectomy; however, this approach may be recommended in patients undergoing Roux-en-Y or Billroth II reconstruction or in patients with diabetes mellitus.

The limitations and possible biases of this study are lack of randomization as a retrospective study, which may cause selective bias. In some groups, the small number of patients may make detection of small differences between study groups unreliable.

Conclusions {#Sec12}
===========

This study showed that prophylactic cholecystectomy may be necessary in gastric cancer patients without Billroth I gastrectomy and with diabetes mellitus. Simultaneous cholecystectomy during gastric cancer surgery does not increase the operative mortality and morbidity rates.
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